MedChemComm
Latest Publications


TOTAL DOCUMENTS

2427
(FIVE YEARS 257)

H-INDEX

54
(FIVE YEARS 14)

Published By The Royal Society Of Chemistry

2040-2511, 2040-2503

MedChemComm ◽  
2019 ◽  
Vol 10 (8) ◽  
pp. 1445-1456 ◽  
Author(s):  
Casey J. Maguire ◽  
Graham J. Carlson ◽  
Jacob W. Ford ◽  
Tracy E. Strecker ◽  
Ernest Hamel ◽  
...  

Cyclic chalcones and structural analogues evaluated as cytotoxic agents.


MedChemComm ◽  
2019 ◽  
Vol 10 (8) ◽  
pp. 1302-1328 ◽  
Author(s):  
Parteek Prasher ◽  
Mousmee Sharma

Contemporary drug discovery approaches rely on library synthesis coupled with combinatorial methods and high-throughput screening to identify leads.


MedChemComm ◽  
2019 ◽  
Vol 10 (8) ◽  
pp. 1370-1378 ◽  
Author(s):  
Chun-Mei Liu ◽  
Jia-Yan Huang ◽  
Li-Xin Sheng ◽  
Xiao-An Wen ◽  
Ke-Guang Cheng

Due to the obvious adverse effects of 5-fluorouracil and considering the diverse biological activities of pentacyclic triterpenes, twelve pentacyclic triterpene-5-fluorouracil conjugates were synthesized and their antitumor activities were evaluated.


MedChemComm ◽  
2019 ◽  
Vol 10 (7) ◽  
pp. 1192-1196 ◽  
Author(s):  
Piera M. Marchetti ◽  
Shona M. Richardson ◽  
Noor M. Kariem ◽  
Dominic J. Campopiano

TamA is the enzyme that controls the acyl chain length of the tambjamine natural products. Here we show that the catalytic ANL domain of TamA can be used to prepare a range of N-acyl amides.


MedChemComm ◽  
2019 ◽  
Vol 10 (5) ◽  
pp. 800-805 ◽  
Author(s):  
Jeffrey L. Henry ◽  
Matthew R. Wilson ◽  
Michael P. Mulligan ◽  
Taylor R. Quinn ◽  
Dan L. Sackett ◽  
...  

Zampanolide and dactylolide are microtubule-stabilizing polyketides possessing potent cytotoxicity towards a variety of cancer cell lines.


MedChemComm ◽  
2019 ◽  
Vol 10 (4) ◽  
pp. 573-583 ◽  
Author(s):  
Runde Xiong ◽  
Dongxiu He ◽  
Xiangping Deng ◽  
Juan Liu ◽  
Xiaoyong Lei ◽  
...  

According to the combination principle, target compounds were designed, and compound E20 might be a promising anti-tumor agent targeting gastric cancer.


MedChemComm ◽  
2019 ◽  
Vol 10 (10) ◽  
pp. 1803-1809 ◽  
Author(s):  
Marat F. Kasakin ◽  
Artem D. Rogachev ◽  
Elena V. Predtechenskaya ◽  
Vladimir J. Zaigraev ◽  
Vladimir V. Koval ◽  
...  

Relapsing–remitting multiple sclerosis markers determined (a) and multivariate models for early diagnosis were evaluated (b).


MedChemComm ◽  
2019 ◽  
Vol 10 (12) ◽  
pp. 2078-2088
Author(s):  
Margherita Mastromarino ◽  
Liliya N. Kirpotina ◽  
Igor A. Schepetkin ◽  
Mark T. Quinn ◽  
Enza Lacivita ◽  
...  

Aurantiamide is a useful scaffold to develop promising FPR1 antagonists capable of inhibiting neutrophil chemotaxis.


MedChemComm ◽  
2019 ◽  
Vol 10 (7) ◽  
pp. 1082-1093 ◽  
Author(s):  
Marco Potowski ◽  
Verena B. K. Kunig ◽  
Florian Losch ◽  
Andreas Brunschweiger

A solid phase-based strategy gave access to DNA-tagged heterocycles by metal-mediated imine chemistry, exemplified by Cushman- and 1,3-dipolar cycloaddition reactions.


MedChemComm ◽  
2019 ◽  
Vol 10 (7) ◽  
pp. 1165-1172 ◽  
Author(s):  
Andrew M. Riley ◽  
Huanchen Wang ◽  
Stephen B. Shears ◽  
Barry V. L. Potter
Keyword(s):  

A synthetic, fluorinated analogue of 5-InsP7binds to the kinase domain of PPIP5K2, suggesting new strategies for designing diphosphoinositol phosphate mimics.


Sign in / Sign up

Export Citation Format

Share Document